2-Hydroxypropyl-β-cyclodextrin-enhanced pharmacokinetics of cabotegravir from a nanofluidic implant for HIV pre-exposure prophylaxis-Reference-Cited by-同舟云学术

2-Hydroxypropyl-β-cyclodextrin-enhanced pharmacokinetics of cabotegravir from a nanofluidic implant for HIV pre-exposure prophylaxis

Published:2019-07 Issue: Volume:306 Page:89-96
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Pons-Faudoa Fernanda P.,Sizovs Antons,Di Trani Nicola^ORCID,Paez-Mayorga Jesus^ORCID,Bruno Giacomo,Rhudy Jessica,Manohar Madhuri,Gwenden Kevin,Martini Cecilia,Chua Corrine Ying Xuan,Varchi Greta^ORCID,Marzinke Mark A.,Grattoni Alessandro

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference57 articles.

1. Prevention of HIV-1 infection with early antiretroviral therapy;Cohen;N. Engl. J. Med.,2011

2. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women;Baeten;N. Engl. J. Med.,2012

3. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men;Grant;N. Engl. J. Med.,2010

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Validation of spectrophotometric and colorimetric methods for determination of efavirenz in various biological matrices: Application to the development of dissolvable microneedle-based efavirenz complex inclusion for vaginal delivery;Microchemical Journal;2024-05

2. Antiviral potency of long-acting islatravir subdermal implant in SHIV-infected macaques;Journal of Controlled Release;2024-02

3. A Bilayer Microarray Patch (MAP) for HIV Pre-Exposure Prophylaxis: The Role of MAP Designs and Formulation Composition in Enhancing Long-Acting Drug Delivery;Pharmaceutics;2024-01-20

4. Intratumoral nanofluidic system enhanced tumor biodistribution of PD‐L1 antibody in triple‐negative breast cancer;Bioengineering & Translational Medicine;2023-09-15

5. Advances in long-acting slow effective release antiretroviral therapies for treatment and prevention of HIV infection;Advanced Drug Delivery Reviews;2023-09